Table 4 Early (30-days) results

Hospital mortality^a, n (%)

1 (1.2)

0

0.313

ICU stay, days

2 (1–14)

2 (1–14)

0.453

Ventilation time, h

7 (0–49)

5 (1–41)

0.068

Inotropic support, h

10 (0–151)

14 (0–105)

0.591

Heart failure, n (%)

23 (27.1)

19 (22.1)

0.451

Prolonged ventilation, n (%)

14 (16.5)

15 (17.4)

0.866

ECLS, n (%)

1 (1.2)

1 (1.2)

0.993

AF Early paroxysm, n (%),

39 (45.9)

30 (34.9)

0.143

Electrical cardioversion, n (%)

7 (8.2)

3 (3.5)

0.186

 MI, n (%)

5 (5.9)

3 (3.5)

0.459

 TIA, n (%)

4 (4.7)

0

0.042

 Stroke, n (%)

0

1 (1.2)

0.319

 AKF, n (%)

5 (5.9)

4 (4.7)

0.719

 IE, n (%)

1 (1.2)

1 (1.2)

0.993

 Ring dehiscence, n (%)

1 (1.2)

0

0.313

 Leak, n (%)

0

0

–

 Thrombosis, n (%)

0

0

–

 Other embolic events, n (%)

0

0

–

 Structural dysfunction, n (%)

0

0

–

Bleeding, n (%);

9 (10.6)

6 (7.0)

0.404

Re-exploration for bleeding, n (%)

4 (4.7)

1 (1.2)

0.169

Lymphorrhea, n (%)

0

1 (1.2)

0.319

Pacemaker implantation, n (%)

5 (5.9)

4 (4.7)

0.719

Pleural effusion, n (%)

14 (16.5)

20 (23.2)

0.266

Deep sternal infection, n (%)

0

0

–

Superficial infection, n (%)

1 (1.2)

1 (1.2)

0.993

Hospital stay, days

17 (9–178)

17 (7–36)

0.455